110 related articles for article (PubMed ID: 31218903)
1. LC-MS/MS method for quantification of 3,4-dihydroxyphenylglycol, a norepinephrine metabolite in plasma and brain regions.
Padala NSP; Ajjala DR; Boggavarapu RK; Pantangi HR; Thentu JB; Mohammed AR; Nirogi R
Bioanalysis; 2019 May; 11(10):971-986. PubMed ID: 31218903
[No Abstract] [Full Text] [Related]
2. Norepinephrine metabolism in neuron: dissociation between 3,4-dihydroxyphenylglycol and 3,4-dihydroxymandelic acid pathways.
Dong WX; Ni XL
Acta Pharmacol Sin; 2002 Jan; 23(1):59-65. PubMed ID: 11860739
[TBL] [Abstract][Full Text] [Related]
3. The neuronal and extraneuronal origins of plasma 3-methoxy-4-hydroxyphenylglycol in rats.
Eisenhofer G; Pecorella W; Pacak K; Hooper D; Kopin IJ; Goldstein DS
J Auton Nerv Syst; 1994 Dec; 50(1):93-107. PubMed ID: 7844319
[TBL] [Abstract][Full Text] [Related]
4. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.
Eisenhofer G; Finberg JP
J Pharmacol Exp Ther; 1994 Mar; 268(3):1242-51. PubMed ID: 8138937
[TBL] [Abstract][Full Text] [Related]
5. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
Palfreyman MG; McDonald IA; Bey P; Schechter PJ; Sjoerdsma A
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):967-87. PubMed ID: 3266532
[TBL] [Abstract][Full Text] [Related]
6. Effects of aldehyde/aldose reductase inhibition on neuronal metabolism of norepinephrine.
Kawamura M; Kopin IJ; Kador PF; Sato S; Tjurmina O; Eisenhofer G
J Auton Nerv Syst; 1997 Oct; 66(3):145-8. PubMed ID: 9406118
[TBL] [Abstract][Full Text] [Related]
7. Liquid chromatographic and tandem mass spectrometric assay for evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors: application of biomarkers in drug discovery.
Lang W; Masucci JA; Caldwell GW; Hageman W; Hall J; Jones WJ; Rafferty BM
Anal Biochem; 2004 Oct; 333(1):79-87. PubMed ID: 15351283
[TBL] [Abstract][Full Text] [Related]
8. Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats.
Kawamura M; Eisenhofer G; Kopin IJ; Kador PF; Lee YS; Tsai JY; Fujisawa S; Lizak MJ; Sinz A; Sato S
Biochem Pharmacol; 1999 Aug; 58(3):517-24. PubMed ID: 10424772
[TBL] [Abstract][Full Text] [Related]
9. Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma.
Hovevey-Sion D; Kopin IJ; Stull RW; Goldstein DS
Neuropharmacology; 1989 Aug; 28(8):791-7. PubMed ID: 2506486
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics and pharmacokinetics of two dose regimens of befloxatone, a new reversible and selective monoamine oxidase inhibitor, at steady state in healthy volunteers.
Patat A; le Coz F; Dubruc C; Gandon JM; Durrieu G; Cimarosti I; Jezequel S; Curet O; Zieleniuk I; Allain H; Rosenzweig P
J Clin Pharmacol; 1996 Mar; 36(3):216-29. PubMed ID: 8690815
[TBL] [Abstract][Full Text] [Related]
11. Unique pentafluorobenzylation and collision-induced dissociation for specific and accurate GC-MS/MS quantification of the catecholamine metabolite 3,4-dihydroxyphenylglycol (DHPG) in human urine.
Zoerner AA; Heusser K; Gutzki FM; Mitschke A; Tank J; Stichtenoth DO; Jordan J; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(17-18):1444-56. PubMed ID: 20638915
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of norepinephrine reuptake inhibition: Modeling the peripheral and central effects of atomoxetine, duloxetine, and edivoxetine on the biomarker 3,4-dihydroxyphenylglycol in humans.
Kielbasa W; Lobo E
J Clin Pharmacol; 2015 Dec; 55(12):1422-31. PubMed ID: 26011686
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
Eisenhofer G; Goldstein DS; Stull R; Keiser HR; Sunderland T; Murphy DL; Kopin IJ
Clin Chem; 1986 Nov; 32(11):2030-3. PubMed ID: 3096593
[TBL] [Abstract][Full Text] [Related]
14. Relative importance of 3-methoxy-4-hydroxyphenylglycol and 3,4-dihydroxyphenylglycol as norepinephrine metabolites in rat, monkey, and humans.
Elsworth JD; Roth RH; Redmond DE
J Neurochem; 1983 Sep; 41(3):786-93. PubMed ID: 6875564
[TBL] [Abstract][Full Text] [Related]
15. Dihydroxyphenylglycol as a Biomarker of Norepinephrine Transporter Inhibition by Atomoxetine: Human Model to Assess Central and Peripheral Effects of Dosing.
Bieck PR; Leibowitz M; Lachno DR; Ledent E; Padich R; Jhee S
J Clin Psychopharmacol; 2016 Dec; 36(6):675-683. PubMed ID: 27755221
[TBL] [Abstract][Full Text] [Related]
16. Norepinephrine metabolites in plasma as indicators of pharmacological inhibition of monoamine oxidase and catechol O-methyltransferase.
Scheinin M; Illi A; Koulu M; Ojala-Karlsson P
Adv Pharmacol; 1998; 42():367-70. PubMed ID: 9327918
[No Abstract] [Full Text] [Related]
17. Mechanistic pharmacokinetic and pharmacodynamic modeling of CHF3381 (2-[(2,3-dihydro-1H-inden-2-yl)amino]acetamide monohydrochloride), a novel N-methyl-D-aspartate antagonist and monoamine oxidase-A inhibitor in healthy subjects.
Csajka C; Imbimbo BP; Piccinno A; Dostert P; Verotta D
J Pharmacol Exp Ther; 2005 May; 313(2):647-57. PubMed ID: 15671203
[TBL] [Abstract][Full Text] [Related]
18. Measurement of plasma norepinephrine and 3,4-dihydroxyphenylglycol: method development for a translational research study.
Denfeld QE; Habecker BA; Woodward WR
BMC Res Notes; 2018 Apr; 11(1):248. PubMed ID: 29673396
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of lazabemide derivatives as inhibitors of monoamine oxidase.
Zhou S; Chen G; Huang G
Bioorg Med Chem; 2018 Sep; 26(17):4863-4870. PubMed ID: 30143367
[TBL] [Abstract][Full Text] [Related]
20. Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans.
Goldstein DS; Cannon RO; Quyyumi A; Chang P; Duncan M; Brush JE; Eisenhofer G
J Auton Nerv Syst; 1991 Jun; 34(1):17-35. PubMed ID: 1940014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
